Pharmacovigilance - Reporting requirements of non-serious ICSRs, applicable to marketing authorisation holders
Marketing authorisation holders are no longer required to submit non-serious individual case safety reports.
MAHs should continue to submit ICSRs for serious cases directly to EudraVigilance (EVHUMAN).